Emerging Science Abstract Submissions Open

Posted on April 5, 2022April 5, 2022 by admin

Emergent Findings With Potentially High Impact Submissions in this category should highlight novel, unanticipated, high-impact or disruptive studies, with a time-sensitive urgency, to present at ASM Microbe. Such findings should have clear public impact and/or advance a field significantly or in...

Clinical Trials and Research

Posted on April 4, 2022April 4, 2022 by admin

Clinical Trials and Research Biobeat’s solution for clinical trials and research enhances clinical data access using our remote monitoring devices alongside our AI tools that are based on experience with more than 10,000 patients and subjects monitored to date, and millions of generated vital s...

Hospital at Home

Posted on April 1, 2022April 1, 2022 by admin

Hospital at Home Solution overview: Especially in times of global pandemics, the world is required to adjust and implement home monitoring solutions. Biobeat tailors to a variety of use-cases, from post-discharge home monitoring, home-hospitalizations and remote patient monitoring. Our platfo...

In Hospital Monitoring

Posted on April 1, 2022April 1, 2022 by admin

In Hospital Monitoring Solution overview: Biobeat’s in-hospital monitoring solution is based on our disposable chest-monitor and enables accurate monitoring of all patients through one cloud-based platform, expanding the continuum of care and providing easy, non-invasive monitoring of vital s...

Biobeat widens lead over Apple, Fitbit with FDA nod to add more vital sign monitoring to smartwatch

Posted on April 1, 2022April 1, 2022 by admin

FDA clears ‘cuffless’ blood pressure tracking smartwatch from Biobeat With its initial FDA clearance in 2019, Biobeat’s wireless, app-connected smartwatch and chest patch became the first devices cleared to measure blood pressure without the use of an inflatable cuff. (Andrew Harnik, Associated...

FDA Clears the Biobeat Remote Patient Monitoring Device and Platform for Additional Vital Signs

Posted on March 30, 2022March 30, 2022 by admin

With Respiratory Rate and Body Temperature Now Cleared, Bio-beat is Leading the Medical Grade Remote Patient Monitoring Market PETAH TIKVA, Israel, March 28, 2022 /PRNewswire/ — Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced to...

Cardiac Output Measurements Using PPG-Based Device to Pulse Contour Cardiac Output in General ICU

Posted on February 21, 2022March 30, 2022 by admin

Cardiac output (CO) measurements in the ICU are usually based on invasive techniques, which are technically complex and associated with clinical complications. The tested chest patch device offers high accuracy for CO compared to data obtained by the pulse contour cardiac output and the thermodil...

Sharing insights on the future of the “Hospital at Home”, by Bio-beat’s CEO- Arik Ben Ishay

Posted on February 21, 2022March 30, 2022 by admin

Biobeat CEO, Arik Ben Ishay, sharing his insights on how the future of “Hospital at Home” care will become a new care reality over the coming years and how technology will empower it. Arik elaborates on: * Changing Patient Attitudes * Medical Economics * Growing Acceptance of Telemedicine by ...

Biobeat’s devices in a joint clinical study

Posted on October 9, 2021March 30, 2022 by admin

From the exponential rise in the use of telehealth to a greater need for decentralized clinical trials and remote monitoring, digital health tools have proven to be valuable – even life-saving – amidst the COVID-19 pandemic. Continued innovation in digital health is critical to further increa...

Biobeat Launches Wearable Continuous ABPM Device

Posted on October 9, 2021March 30, 2022 by admin

Biobeat Wearable non-invasive devices. Ambulatory Blood Pressure Monitoring Device

ADOLYSYS

Category: News

Emerging Science Abstract Submissions Open

Clinical Trials and Research

Hospital at Home

In Hospital Monitoring

Biobeat widens lead over Apple, Fitbit with FDA nod to add more vital sign monitoring to smartwatch

FDA Clears the Biobeat Remote Patient Monitoring Device and Platform for Additional Vital Signs

Cardiac Output Measurements Using PPG-Based Device to Pulse Contour Cardiac Output in General ICU

Sharing insights on the future of the “Hospital at Home”, by Bio-beat’s CEO- Arik Ben Ishay

Biobeat’s devices in a joint clinical study

Biobeat Launches Wearable Continuous ABPM Device